16-Alpha-gitoxin

Drug Profile

16-Alpha-gitoxin

Alternative Names: 16Alpha-gitoxin

Latest Information Update: 09 Dec 1998

Price : $50

At a glance

  • Originator Nonindustrial source
  • Class Cardiac glycosides; Cardiotonics
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Heart failure

Most Recent Events

  • 09 Dec 1998 No-Development-Reported for Heart failure in Germany (Unknown route)
  • 15 Nov 1995 Phase-I clinical trials for Heart failure in Germany (Unknown route)
  • 15 Nov 1995 New profile
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top